Our previous works have shown that in mouse models of retinal detachment and AMD, treatment by Met12, a precursor molecule to INL1204, inhibited Fas-mediated caspase 8 activation [7, 12], and reduced activities of caspase 3 and caspase 9 as well [7]. This evidence concerns the gene CASP3 and retinal detachment.